CDC stated in its Weekly U.S. Influenza Surveillance Report, FluView, that as of the week ending December 29, influenza activity was increasing in the U.S. Two influenza-associated pediatric deaths were reported to CDC during week 52, for a total of 13 influenza-associated pediatric deaths reported for the 2018–2019 season. At this time, hospitalization rates in children younger than 5 years old (14.5 per 100,000) are the highest among all age groups. Last season, there was a record-setting number of pediatric deaths in the U.S. (172), so be sure to protect all your patients for whom vaccination is recommended.

Influenza vaccination is recommended for everyone six months of age and older. If you don’t provide influenza vaccination in your clinic, please recommend vaccination to your patients and refer them to a clinic or pharmacy that provides vaccines or to the HealthMap Vaccine Finder to locate sites near their workplaces or homes that offer influenza vaccination services.

American Cancer Society

The death rate from cancer in the U.S. has declined steadily over the past 25 years, according to annual statistics reporting from the American Cancer Society. As of 2016, the cancer death rate for men and women combined had fallen 27 percent from its peak in 1991. This decline translates to about 1.5 percent per year and more than 2.6 million deaths avoided between 1991 and 2016.

The drop in cancer mortality is mostly due to steady reductions in smoking and advances in early detection and treatment. But not all populations are benefiting. Although the racial gap in cancer deaths is slowly narrowing, socioeconomic inequalities are widening. “Cancer Statistics, 2019,” published in the American Cancer Society’s journal CA: A Cancer Journal for Clinicians, estimates the numbers of new cancer cases and deaths expected in the U.S. this year. The estimates are some of the most widely quoted cancer statistics in the world. The information is also released in a companion report, Cancer Facts and Figures 2019, available on the interactive website, the Cancer Statistics Center.

A total of 1,762,450 new cancer cases and 606,880 deaths from cancer are expected to occur in the U.S. in 2019. During the most recent decade of available data (2006 – 2015), the rate of new cancer diagnoses decreased by about 2 percent per year in men and stayed about the same in women. The cancer death rate (2007 – 2016) declined by 1.4 percent per year in women and 1.8 percent per year in men.


AAFP has two Leadership Conferences you are encouraged to attend if interested in leadership opportunities! AAFP’s National Conference of Constituency Leaders (NCCL) and AAFP Leadership Conference are both held in Kansas City, Missouri, April 25-27, 2019 (pre-conference April 24).

The Leadership Conference serves as a great orientation for emerging leaders who serve, or who are interested in serving, on the KAFP board or in leadership positions in other organizations. NCCL is the AAFP’s forum to address member issues specific to women, minorities, new physicians, international medical graduates (IMG) and GLBT physicians. The KAFP is seeking representatives from the following categories to attend: IMG, new physician, women, and minorities. By Board policy, KAFP will reimburse designated representatives to attend. Contact Carolyn or 316-721-9005) with a note expressing your interest by March 1, 2019.


The 2019 Kansas Legislative Session started yesterday, January 14!  Join us in welcoming Governor Kelly and a new House of Representatives. There will be opportunities to improve the health of Kansans as well as challenges to previous gains. Please join us in actively supporting and promoting these initiatives that put the health of Kansans first! As an advocate, you will receive email updates “Legislative Update” on the progress of the Kansas Academy of Family Physicians legislative efforts by KAFP Government Relations Liaison Dodie Wellshear.  You may be asked to take action via email, phone calls, and visits with your legislators. Together, we will make a difference in the lives of Kansans.  There are three things you can do to help us have a successful legislative session:



The legislative session is right around the corner!  The legislative session kicks off January 14 with President Jeremy Presley, MD, FAAFP serving as the Family Doctor of the Day (FDOD) for the first two days. We invite all of our active members (including residents) with a Kansas license, to serve as the FDOD at the Statehouse during the legislative session. Please check your calendars and see if you are available.

Your time is appreciated! 

Upcoming open dates include:
February 1, 5
March 12, 13, 18, 19, 20, 25, 26

FDOD volunteers report to the Capitol Building in Topeka at 9:00 a.m. and stay until 3:00 p.m. taking care of legislators, staff and sometimes even visitors who need medical attention.

Thank you to all of our FDOD volunteers!

IAC Express

CDC reports that flu activity is elevated and 11 children have died of influenza; please keep vaccinating your patients.

CDC stated in its Weekly U.S. Influenza Surveillance Report, FluView, that as of the week ending December 22, influenza activity was increasing in the U.S. Four influenza-associated pediatric deaths were reported to CDC during week 51, for a total of 11 influenza-associated pediatric deaths reported for the 2018–2019 season. Last season, there was a record-setting number of pediatric deaths in the U.S. (172), so be sure to protect all your patients for whom vaccination is recommended.

Access the CDC complete report: 2018–2019 Flu Season: Flu Activity Elevated Nationally.


Attention KanCare providers: The information card explaining the expanded KanCare benefits for tobacco cessation has been updated to include 2019 KanCare MCOs. Thank you for your continued partnership in providing this information to your patients. Please print the information cards in-house or contact Kim Neufeld to request a quantity of the printed cards. Download 2019 KanCare Tobacco Cessation Card.


The National Health Service Corps (NHSC) seeks clinicians who want to serve the nation’s underserved rural, urban and tribal communities. The NHSC Loan Repayment Program (NHSC LRP) offers licensed primary care clinicians in eligible disciplines the opportunity to receive loan repayment up to $50,000. In exchange, participants serve for at least two years at an NHSC-approved site in a designated Health Professional Shortage Area (HPSA).

Application Deadline: February 21, 6:30 p.m.



Effective January 1, 2019, CMS announced new strategies to further help Medicare Part D sponsors prevent and combat opioid overuse including additional safety alerts at the time of dispensing as a proactive step to engage both patients and prescribers about overdose risk and prevention.

The CMS advises, “As the new opioid safety alerts are implemented in 2019, on-going communication among the pharmacist, the Part D plan, and the prescriber will be critical. Physicians and other prescribers can protect their patients’ access to medically necessary drugs by responding to pharmacists’ or plan sponsors’ telephone calls or case management notices. Providers will also want to initiate coverage determinations or exceptions, when clinically appropriate. To avoid a prescription being rejected at the pharmacy, prescribers may proactively request a coverage determination in advance.  The time frame for an expedited coverage determination request applies when the prescriber indicates, or the plan decides, that applying the standard time frame may seriously jeopardize the enrollee’s life, health, or ability to regain maximum function. If the request meets the criteria for an expedited review by the plan, the plan must make its decision and notify the patient as expeditiously as their health condition requires, but no later than 24 hours after receipt of the request.”

Visit the CMS website for further information.


One Health Commission

The One Health Academy, Washington DC presents Dennis Carroll, PhD, who currently serves as the director of the U.S. Agency for International Development’s (USAID’s) Global Health Security and Development Unit.

The Future is Coming! Is One Health Ready?
Wednesday, January 9
5:45 p.m.
Registration is free but registration is required for login.

Dr. Carroll is responsible for providing strategic and operational leadership for the agency’s programs addressing new and emerging disease threats. Dr. Carroll also serves as USAID’s special representative for global health security. Dr. Carroll was initially detailed to USAID from the U.S. Centers for Disease Control and Prevention (CDC) as a senior public health advisor in 1991. In 1995 he was named the agency’s senior infectious diseases advisor, responsible for overseeing the agency’s programs in malaria, tuberculosis, antimicrobial resistance, disease surveillance, as well as neglected and emerging infectious diseases. In this capacity Dr. Carroll was directly involved in the development and introduction of a range of new technologies for disease prevention and control, including: community-based delivery of treatment of onchocerciasis, rapid diagnostics for malaria, new treatment therapies for drug-resistant malaria, intermittent therapy for pregnant women, and “long-lasting” insecticide treated bed nets for prevention of malaria. He was responsible for the initial design and development of the President’s Malaria Initiative. Dr. Carroll officially left CDC and joined USAID in 2005 when he assumed responsibility for leading the USAID response to the spread of avian influenza.

Dr. Carroll has a doctorate in biomedical research with a special focus in tropical infectious diseases from the University of Massachusetts at Amherst. He was a research scientist at Cold Spring Harbor Laboratory where he studied the molecular mechanics of viral infection. Dr. Carroll has received awards from both CDC and USAID, including the 2006 USAID Science and Technology Award for his work on malaria and avian influenza, and the 2008 Administrator’s Management Innovation Award for his management of the agency’s Avian and Pandemic Influenza program.